These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27491687)

  • 21. Maternal death: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
    Patwardhan M; Eckert LO; Spiegel H; Pourmalek F; Cutland C; Kochhar S; Gonik B;
    Vaccine; 2016 Dec; 34(49):6077-6083. PubMed ID: 27426627
    [No Abstract]   [Full Text] [Related]  

  • 22. Reporting of vaccine safety data in publications: systematic review.
    Bonhoeffer J; Zumbrunn B; Heininger U
    Pharmacoepidemiol Drug Saf; 2005 Feb; 14(2):101-6. PubMed ID: 15386705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study.
    Gold MS; Gidudu J; Erlewyn-Lajeunesse M; Law B;
    Vaccine; 2010 Jun; 28(28):4487-98. PubMed ID: 20434547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy.
    Jones CE; Munoz FM; Kochhar S; Vergnano S; Cutland CL; Steinhoff M; Black S; Heininger U; Bonhoeffer J; Heath PT
    Vaccine; 2016 Dec; 34(49):6007-6014. PubMed ID: 27793485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation.
    DeSilva M; Munoz FM; Sell E; Marshall H; Tse Kawai A; Kachikis A; Heath P; Klein NP; Oleske JM; Jehan F; Spiegel H; Nesin M; Tagbo BN; Shrestha A; Cutland CL; Eckert LO; Kochhar S; Bardají A;
    Vaccine; 2017 Dec; 35(48 Pt A):6472-6482. PubMed ID: 29150052
    [No Abstract]   [Full Text] [Related]  

  • 26. Applicability, reliability, sensitivity, and specificity of six Brighton Collaboration standardized case definitions for adverse events following immunization.
    Kohl KS; Magnus M; Ball R; Halsey N; Shadomy S; Farley TA
    Vaccine; 2008 Nov; 26(50):6349-60. PubMed ID: 18805456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global alignment of immunization safety assessment in pregnancy - The GAIA project.
    Bonhoeffer J; Kochhar S; Hirschfeld S; Heath PT; Jones CE; Bauwens J; Honrado Á; Heininger U; Muñoz FM; Eckert L; Steinhoff M; Black S; Padula M; Sturkenboom M; Buttery J; Pless R; Zuber P;
    Vaccine; 2016 Dec; 34(49):5993-5997. PubMed ID: 27751641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathways to preterm birth: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
    Harrison MS; Eckert LO; Cutland C; Gravett M; Harper DM; McClure EM; Nunes AP; Lazo S; Moore TM; Watson W; Kochhar S; Goldenberg RL;
    Vaccine; 2016 Dec; 34(49):6093-6101. PubMed ID: 27491689
    [No Abstract]   [Full Text] [Related]  

  • 29. The measurement and monitoring of surgical adverse events.
    Bruce J; Russell EM; Mollison J; Krukowski ZH
    Health Technol Assess; 2001; 5(22):1-194. PubMed ID: 11532239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data.
    Tavares Da Silva F; Gonik B; McMillan M; Keech C; Dellicour S; Bhange S; Tila M; Harper DM; Woods C; Kawai AT; Kochhar S; Munoz FM;
    Vaccine; 2016 Dec; 34(49):6057-6068. PubMed ID: 27431422
    [No Abstract]   [Full Text] [Related]  

  • 31. IgA vasculitis (Henoch-Schönlein): Case definition andguidelines for data collection, analysis, and presentation of immunisation safety data.
    Woerner A; Rudin C; Bonetto C; Santuccio C; Ozen S; Wise RP; Chandler R; Bonhoeffer J;
    Vaccine; 2017 Mar; 35(11):1559-1566. PubMed ID: 28034474
    [No Abstract]   [Full Text] [Related]  

  • 32. Postpartum haemorrhage: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
    Kerr R; Eckert LO; Winikoff B; Durocher J; Meher S; Fawcus S; Mundle S; Mol B; Arulkumaran S; Khan K; Wandwabwa J; Kochhar S; Weeks A;
    Vaccine; 2016 Dec; 34(49):6102-6109. PubMed ID: 27431424
    [No Abstract]   [Full Text] [Related]  

  • 33. Subcutaneous nodules: an important adverse event following immunization.
    Silcock R; Crawford NW; Perrett KP
    Expert Rev Vaccines; 2019 Apr; 18(4):405-410. PubMed ID: 30808246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kawasaki disease and immunisation: A systematic review.
    Phuong LK; Bonetto C; Buttery J; Pernus YB; Chandler R; Felicetti P; Goldenthal KL; Kucuku M; Monaco G; Pahud B; Shulman ST; Top KA; Trotta F; Ulloa-Gutierrez R; Varricchio F; de Ferranti S; Newburger JW; Dahdah N; Singh S; Bonhoeffer J; Burgner D;
    Vaccine; 2017 Mar; 35(14):1770-1779. PubMed ID: 28259442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women.
    Jones CE; Munoz FM; Spiegel HM; Heininger U; Zuber PL; Edwards KM; Lambach P; Neels P; Kohl KS; Gidudu J; Hirschfeld S; Oleske JM; Khuri-Bulos N; Bauwens J; Eckert LO; Kochhar S; Bonhoeffer J; Heath PT;
    Vaccine; 2016 Dec; 34(49):5998-6006. PubMed ID: 27481360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-reassuring fetal status: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Gravett C; Eckert LO; Gravett MG; Dudley DJ; Stringer EM; Mujobu TB; Lyabis O; Kochhar S; Swamy GK;
    Vaccine; 2016 Dec; 34(49):6084-6092. PubMed ID: 27461459
    [No Abstract]   [Full Text] [Related]  

  • 37. Neonatal seizures: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Pellegrin S; Munoz FM; Padula M; Heath PT; Meller L; Top K; Wilmshurst J; Wiznitzer M; Das MK; Hahn CD; Kucuku M; Oleske J; Vinayan KP; Yozawitz E; Aneja S; Bhat N; Boylan G; Sesay S; Shrestha A; Soul JS; Tagbo B; Joshi J; Soe A; Maltezou HC; Gidudu J; Kochhar S; Pressler RM;
    Vaccine; 2019 Dec; 37(52):7596-7609. PubMed ID: 31783981
    [No Abstract]   [Full Text] [Related]  

  • 38. Obstetrical and neonatal case definitions for immunization safety data.
    Chen RT; Moro PL; Bauwens J; Bonhoeffer J
    Vaccine; 2016 Dec; 34(49):5991-5992. PubMed ID: 27554535
    [No Abstract]   [Full Text] [Related]  

  • 39. Vaccines for maternal immunization against Group B Streptococcus disease: WHO perspectives on case ascertainment and case definitions.
    Seale AC; Baker CJ; Berkley JA; Madhi SA; Ordi J; Saha SK; Schrag SJ; Sobanjo-Ter Meulen A; Vekemans J
    Vaccine; 2019 Aug; 37(35):4877-4885. PubMed ID: 31303524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
    DeSilva M; Munoz FM; Mcmillan M; Kawai AT; Marshall H; Macartney KK; Joshi J; Oneko M; Rose AE; Dolk H; Trotta F; Spiegel H; Tomczyk S; Shrestha A; Kochhar S; Kharbanda EO;
    Vaccine; 2016 Dec; 34(49):6015-6026. PubMed ID: 27435386
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.